HighTower Advisors’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-177,637
| Closed | -$17.6M | – | 2640 |
|
|
2019
Q3 | $17.6M | Sell |
177,637
-42,407
| -19% | -$4.03M | 0.1% | 219 |
|
|
2019
Q2 | $20.3M | Sell |
220,044
-3,223
| -1% | -$306K | 0.12% | 181 |
|
|
2019
Q1 | $21.1M | Sell |
223,267
-1,534
| -0.7% | -$134K | 0.14% | 154 |
|
|
2018
Q4 | $14.4M | Sell |
224,801
-87,779
| -28% | -$6.48M | 0.11% | 195 |
|
|
2018
Q3 | $28M | Buy |
312,580
+74,555
| +31% | +$6.59M | 0.2% | 98 |
|
|
2018
Q2 | $18.9M | Sell |
238,025
-3,329
| -1% | -$276K | 0.15% | 144 |
|
|
2018
Q1 | $21.5M | Sell |
241,354
-34,398
| -12% | -$3.3M | 0.18% | 123 |
|
|
2017
Q4 | $28.8M | Sell |
275,752
-13,495
| -5% | -$1.52M | 0.24% | 93 |
|
|
2017
Q3 | $42.1M | Sell |
289,247
-5,177
| -2% | -$705K | 0.36% | 52 |
|
|
2017
Q2 | $38.2M | Buy |
294,424
+8,305
| +3% | +$1.02M | 0.34% | 55 |
|
|
2017
Q1 | $35.5M | Buy |
286,119
+53,542
| +23% | +$6.41M | 0.34% | 52 |
|
|
2016
Q4 | $26.9M | Buy |
232,577
+15,346
| +7% | +$1.71M | 0.29% | 69 |
|
|
2016
Q3 | $22.7M | Buy |
217,231
+4,717
| +2% | +$511K | 0.26% | 79 |
|
|
2016
Q2 | $20.9M | Sell |
212,514
-61,287
| -22% | -$6.34M | 0.27% | 79 |
|
|
2016
Q1 | $27.5M | Buy |
273,801
+39,238
| +17% | +$4.04M | 0.09% | 73 |
|
|
2015
Q4 | $28.1M | Buy |
234,563
+16,553
| +8% | +$1.92M | 0.33% | 60 |
|
|
2015
Q3 | $23.6M | Buy |
218,010
+159,688
| +274% | +$19.8M | 0.31% | 69 |
|
|
2015
Q2 | $6.77M | Sell |
58,322
-109,618
| -65% | -$12.5M | 0.11% | 202 |
|
|
2015
Q1 | $19.4M | Sell |
167,940
-19,452
| -10% | -$2.32M | 0.29% | 69 |
|
|
2014
Q4 | $21M | Sell |
187,392
-1,288
| -0.7% | -$136K | 0.32% | 68 |
|
|
2014
Q3 | $17.9M | Buy |
188,680
+21,297
| +13% | +$1.92M | 0.3% | 68 |
|
|
2014
Q2 | $15.8M | Sell |
167,383
-27,247
| -14% | -$2.07M | 0.27% | 74 |
|
|
2014
Q1 | $13.6M | Sell |
194,630
-21,086
| -10% | -$1.67M | 0.26% | 79 |
|
|
2013
Q4 | $18.2M | Buy |
215,716
+31,856
| +17% | +$2.52M | 0.37% | 52 |
|
|
2013
Q3 | $14.2M | Sell |
183,860
-3,448
| -2% | -$242K | 0.35% | 60 |
|
|
2013
Q2 | $11M | Buy |
+187,308
| New | +$11.3M | 0.3% | 70 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
HighTower Advisors's CELG Position: Q4 2019 in Review
HighTower Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 177,637 shares — an estimated $17.6M sold.
HighTower Advisors first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $42.1M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- HighTower Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- HighTower Advisors sold 177,637 Celgene Corp shares in Q4 2019, an estimated $17.6M.
- HighTower Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- HighTower Advisors's Celgene Corp position peaked at $42.1M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on HighTower Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.